CRISPR “Gene Drive” Reverses Antibiotic Resistance in Bacteria - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

CRISPR “Gene Drive” Reverses Antibiotic Resistance in Bacteria

Population-wide editing system strips resistance genes – even inside hard-to-treat biofilms

  • April 2, 2026

  • 2 min

Share

  • 1

    A CRISPR-based system can reverse antibiotic resistance in bacteria by removing resistance genes instead of killing the bacteria.

  • 2

    The new tool, pPro-MobV, enhances gene transfer through a conjugation-based system, allowing efficient spread among bacterial cells.

  • 3

    Laboratory experiments demonstrated a reduction of antibiotic-resistant bacteria by three to five orders of magnitude.

  • 4

    The system effectively targets biofilms, which are challenging to eliminate and often associated with chronic infections.

  • 5

    The platform includes a safeguard for gene removal and potential applications in clinical, environmental, and industrial settings.

Original Source(s)

CRISPR “Gene Drive” Reverses Antibiotic Resistance in Bacteria

  • April 2, 2026

Related Content

Distribution of quorum-sensing genes (lasI, lasR, RhlI, and rhlR) among clinical isolates of biofilm-forming Pseudomonas aeruginosa in Northern Iran

Alopecia Associated with Isoniazid in Cases of Isoniazid-Monoresistant Pulmonary Tuberculosis

Antibiotics May Not Help Mild COVID

A retrospective cohort study of more than 520,000 hospitalized patients found no clinically meaningful improvement in deterioration or mortality with early treatment targeting community-acquired pneumonia.